Perrigo UK, the pharmaceutical giant behind brands including Solpadeine, Nytol and Niquitin, is overhauling its digital strategy with the appointment of Leeds-based independent agency Brass to work across its entire UK brand portfolio.
The agency, which has handled the GlaxoSmithKline consumer healthcare sector business for 12 years, will be looking to upgrade Perrigo’s entire digital ecosystem, increasing the company’s digital visibility.
Brass will work closely to integrate with other agencies and will be focusing on delivering effective digital solutions.
This is the agency’s first win since it refocused its proposition which to design and deliver effective consumer experiences across UX, content development and acquisition.
Perrigo senior marketing director Holly Turner said: “We were really impressed with Brass’ strategic thinking, flexibility and understanding of the consumer healthcare market and we’re looking forward to welcoming them as our lead digital agency partner.”
Brass managing partner Gill Ball added: “We’re thrilled that Perrigo wants to collaborate with Brass to help deliver its digital ambition.”
Founded in 1983, Brass works with clients including First Direct, Coty, Lucozade Ribena Suntory and CBBC.
GlaxoSmithKline in CRM shake-up